Cleared Traditional

K903462 - OPTIMED GLAUCOMA PRESSURE REGULATOR

K903462 is an FDA 510(k) clearance for OPTIMED GLAUCOMA PRESSURE REGULATOR, manufactured by Optimed, Inc.. The device is a Class 2 Ophthalmic device with product code KYF cleared through the Traditional 510(k) pathway after a 76-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1990
Decision
76d
Days
Class 2
Risk

K903462 is an FDA 510(k) clearance for the OPTIMED GLAUCOMA PRESSURE REGULATOR. Classified as Implant, Eye Valve (product code KYF), Class II - Special Controls.

Submitted by Optimed, Inc. (Santa Barbara, US). The FDA issued a Cleared decision on October 16, 1990 after a review of 76 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.3920 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K903462

510(k) Number K903462 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 1990
Decision Date October 16, 1990
Days to Decision 76 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 110d · This submission: 76d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KYF Device Classification - Class 2, Special Controls

Product Code KYF Implant, Eye Valve
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.3920
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - KYF Implant, Eye Valve

All 24
Devices cleared under the same product code (KYF) and FDA review panel - the closest regulatory comparables to K903462.
KRUPIN EYE VALVE WITH DISK
K905703 · Hood Laboratories · Mar 1991
TRABECULO-SUPRACHOROIDAL SHUNT
K902296 · Visionex, Inc. · Mar 1991
BAERVELDT GLAUCOMA IMPLANT
K905129 · Wright Medical Corp. · Feb 1991
MODIFIED MOLTENO(TM) IMPLANTS
K902489 · Iop, Inc. · Aug 1990
MOLTENO IMPLANT
K890598 · Iop, Inc. · Feb 1989
KRUPIN EYE VALVE W/SCLERAL BUCKLE
K885125 · Hood Laboratories · Jan 1989